TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,715,000 | +674.2% | 62,660 | +176.1% | 0.05% | +1150.0% |
| Q1 2022 | $609,000 | +27.9% | 22,698 | +127.5% | 0.00% | +33.3% |
| Q4 2021 | $476,000 | -86.5% | 9,976 | -81.2% | 0.00% | -82.4% |
| Q3 2021 | $3,519,000 | +95.8% | 52,976 | +130.0% | 0.02% | +112.5% |
| Q2 2021 | $1,797,000 | -26.0% | 23,037 | -10.3% | 0.01% | -38.5% |
| Q1 2021 | $2,429,000 | -7.6% | 25,676 | +19.0% | 0.01% | -7.1% |
| Q4 2020 | $2,629,000 | +364.5% | 21,573 | +233.2% | 0.01% | +250.0% |
| Q3 2020 | $566,000 | +17.9% | 6,475 | -12.9% | 0.00% | 0.0% |
| Q2 2020 | $480,000 | +66.7% | 7,436 | +15.2% | 0.00% | +33.3% |
| Q1 2020 | $288,000 | +22.0% | 6,456 | +70.7% | 0.00% | +50.0% |
| Q4 2019 | $236,000 | -83.9% | 3,782 | -90.3% | 0.00% | -83.3% |
| Q3 2019 | $1,464,000 | – | 38,935 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |